Discovery of Potent and Selective Inhibitors of the Mammalian Target of Rapamycin (mTOR) Kinase
- 19 October 2009
- journal article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 52 (22), 7081-7089
- https://doi.org/10.1021/jm9012642
Abstract
The mammalian target of rapamycin (mTOR) is a central regulator of cell growth, metabolism, and angiogenesis and an emerging target in cancer research. High throughput screening (HTS) of our compound collection led to the identification of 3-(4-morpholin-4-yl-1-piperidin-4-yl-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenol (5a), a modestly potent and nonselective inhibitor of mTOR and phosphoinositide 3-kinase (PI3K). Optimization of compound 5a, employing an mTOR homology model based on an X-ray crystal structure of closely related PI3Kγ led to the discovery of 6-(1H-indol-5-yl)-4-morpholin-4-yl-1-[1-(pyridin-3-ylmethyl)piperidin-4-yl]-1H-pyrazolo[3,4-d]pyrimidine (5u), a potent and selective mTOR inhibitor (mTOR IC50 = 9 nM; PI3Kα IC50 = 1962 nM). Compound 5u selectively inhibited cellular biomarker of mTORC1 (P-S6K, P-4EBP1) and mTORC2 (P-AKT S473) over the biomarker of PI3K/PDK1 (P-AKT T308) and did not inhibit PI3K-related kinases (PIKKs) in cellular assays. These pyrazolopyrimidines represent an exciting new series of mTOR-selective inhibitors with potential for development for cancer therapy.Keywords
This publication has 28 references indexed in Scilit:
- The Pharmacology of mTOR InhibitionScience Signaling, 2009
- The PTEN–PI3K pathway: of feedbacks and cross-talksOncogene, 2008
- PI3K pathway alterations in cancer: variations on a themeOncogene, 2008
- Targeting the mTOR signaling network in cancerTrends in Molecular Medicine, 2007
- Defining the Role of mTOR in CancerCancer Cell, 2007
- TOR Signaling in Growth and MetabolismCell, 2006
- Growing roles for the mTOR pathwayCurrent Opinion in Cell Biology, 2005
- Dysregulation of the TSC-mTOR pathway in human diseaseNature Genetics, 2004
- PI 3-kinase related kinases: ‘big’ players in stress-induced signaling pathwaysDNA Repair, 2004
- Structure of the FKBP12-Rapamycin Complex Interacting with Binding Domain of Human FRAPScience, 1996